Latest Commercialisation News

InteliCare has launched a three-month trial of its AI-powered platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy with a leading aged care provider.

BMG Resources confirms a substantial gold system at its Abercromby Gold Project through Phase 1 drilling results, validating its geological model and setting the stage for resource expansion. The company is advancing plans for Phase 2 drilling and a scoping study to explore commercial mining potential.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Sunshine Metals has completed resource infill drilling at its Plateau gold-silver prospect and reconnaissance drilling at the Salla gold-copper-zinc prospect, delivering results that support an upcoming resource update and further exploration.

Nanoveu Limited has raised A$2 million through a strategic placement to accelerate the commercialisation of its 16nm ECS-DoT chip and expand its EMASS modular AIoT platform, positioning the company for global growth.

Buru Energy has agreed to sell its hydrogen-focused subsidiary 2H Resources and non-core Canning Basin assets to Koloma Australia for up to AUD 2 million, marking a strategic pivot towards its Rafael Gas Project.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Emperor Energy has raised $3.7 million through a share placement to advance the Judith-2 appraisal well in Victoria’s Gippsland Basin, backed by independent resource validation and strategic infrastructure proximity.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.